Table 2. The genotype distributions of TLR9-1486 T/C in cases and controls.
Genotype | Controls (314) | Patients (314) | Crude OR | Gastric Carcinoma | ||||||
No. | % | No. | % | 95% CI | P | Adjusted ORa | 95% CI | P | ||
TT | 122 | 38.9% | 94 | 29.9% | 1.00 | |||||
TC | 148 | 47.1% | 164 | 52.2% | 1.44 | 1.02–2.04 | 0.04 | 1.47 | 1.04–2.10 | 0.03 |
CC | 44 | 14.1% | 56 | 17.8% | 1.65 | 1.02–2.66 | 0.04 | 1.63 | 1.01–2.64 | 0.04 |
Recessive model | ||||||||||
Others | 270 | 85.9% | 258 | 82.2% | 1.00 | |||||
CC | 44 | 14.1% | 56 | 17.8% | 1.33 | 0.87–2.05 | 0.19 | 1.33 | 0.86–2.05 | 0.20 |
Dominant model | ||||||||||
TT | 122 | 38.9% | 94 | 29.9% | 1.00 | |||||
Others | 192 | 61.1% | 220 | 70.1% | 1.49 | 1.07–2.07 | 0.02 | 1.51 | 1.08–2.11 | 0.02 |
Adjusted for age, sex, and H. pylori infection.
OR, odds ratio; CI, confidence interval.